Sign In
Last checked at 
31 May 2019 16:06
31 May 2019
Kainos Group plc
("Kainos" or the "Company")
Total Voting Rights
Pursuant to DTR 5.6.1 the Company announces that as at 31 May 2019, the total number of ordinary shares in issue now stands at 121,022,158 each with voting rights. There are no shares held in treasury.
The above figure (121,022,158) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47
Classification: 2.5 - Total number of voting rights and capital
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc +44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.
The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.
The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS.
Kainos has over 1,400 people across twelve offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com
Follow the stocks
